Haixi Pharma Surges 103% in Hong Kong Grey Market
View all comments(0)
Chinese drugmaker Haixi Pharma shares surged 103% in Hong Kong grey market.

Haixi Pharmaceuticals was established in Fuzhou in March 2012. Haixi Pharma is a pharmaceutical enterprise built around the Marketing Authorization Holder (MAH) system, covering the entire industry value chain from R&D, clinical research, and manufacturing to commercialization.
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Like
Recommended Articles
Featured Tools
Top News
Meta Connect 2026 New Product Roundup: Muse Integrated Into AI Glasses, Can It Drive Meta Revenue Growth?

Meta Stock Forecast: Muse Monetization Path Is Key as JPMorgan Raises Price Target to $920; Can Stock Hit Record High?

US Stocks Mixed as Dow Drops 160 Points; Tech Stocks Lead, Meta Rises 4.5%

Oracle Tumbles 7% as Project Jupiter Data Center Force Majeure Notice Sparks Delay Concerns

Qualcomm Extends Long-Term Patent Agreement With Apple, Securing QTL Revenue in Era of In-House iPhone Modems





Comments (0)
Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.